238 related articles for article (PubMed ID: 22451501)
1. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
2. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
Bloom J; Hinrichs AL; Wang JC; von Weymarn LB; Kharasch ED; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2011 Jul; 21(7):403-16. PubMed ID: 21597399
[TBL] [Abstract][Full Text] [Related]
3. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.
Schoedel KA; Hoffmann EB; Rao Y; Sellers EM; Tyndale RF
Pharmacogenetics; 2004 Sep; 14(9):615-26. PubMed ID: 15475735
[TBL] [Abstract][Full Text] [Related]
4. Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
Piliguian M; Zhu AZ; Zhou Q; Benowitz NL; Ahluwalia JS; Sanderson Cox L; Tyndale RF
Pharmacogenet Genomics; 2014 Feb; 24(2):118-28. PubMed ID: 24305170
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
[TBL] [Abstract][Full Text] [Related]
6. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.
Mwenifumbo JC; Al Koudsi N; Ho MK; Zhou Q; Hoffmann EB; Sellers EM; Tyndale RF
Hum Mutat; 2008 May; 29(5):679-88. PubMed ID: 18360915
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; Sakai H; McLeod HL; Yokoi T
Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
[TBL] [Abstract][Full Text] [Related]
8. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
9. A novel duplication type of CYP2A6 gene in African-American population.
Fukami T; Nakajima M; Yamanaka H; Fukushima Y; McLeod HL; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):515-20. PubMed ID: 17267622
[TBL] [Abstract][Full Text] [Related]
10. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
11. Haplotypes with copy number and single nucleotide polymorphisms in CYP2A6 locus are associated with smoking quantity in a Japanese population.
Kumasaka N; Aoki M; Okada Y; Takahashi A; Ozaki K; Mushiroda T; Hirota T; Tamari M; Tanaka T; Nakamura Y; Kamatani N; Kubo M
PLoS One; 2012; 7(9):e44507. PubMed ID: 23049750
[TBL] [Abstract][Full Text] [Related]
12. New CYP2A6 gene deletion and conversion variants in a population of Black African descent.
Mwenifumbo JC; Zhou Q; Benowitz NL; Sellers EM; Tyndale RF
Pharmacogenomics; 2010 Feb; 11(2):189-98. PubMed ID: 20136358
[TBL] [Abstract][Full Text] [Related]
13. Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
Bloom AJ; Baker TB; Chen LS; Breslau N; Hatsukami D; Bierut LJ; Goate A
Hum Mol Genet; 2014 Jan; 23(2):555-61. PubMed ID: 24045616
[TBL] [Abstract][Full Text] [Related]
14. The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.
Bloom AJ; von Weymarn LB; Martinez M; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2013 Dec; 23(12):706-16. PubMed ID: 24192532
[TBL] [Abstract][Full Text] [Related]
15. Associations of CYP2A6 genotype with smoking behaviors in southern China.
Liu T; David SP; Tyndale RF; Wang H; Zhou Q; Ding P; He YH; Yu XQ; Chen W; Crump C; Wen XZ; Chen WQ
Addiction; 2011 May; 106(5):985-94. PubMed ID: 21205058
[TBL] [Abstract][Full Text] [Related]
16. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
17. A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; McLeod HL; Yokoi T
Biochem Pharmacol; 2005 Sep; 70(5):801-8. PubMed ID: 15993850
[TBL] [Abstract][Full Text] [Related]
18. CYP2A6 metabolism in the development of smoking behaviors in young adults.
Olfson E; Bloom J; Bertelsen S; Budde JP; Breslau N; Brooks A; Culverhouse R; Chan G; Chen LS; Chorlian D; Dick DM; Edenberg HJ; Hartz S; Hatsukami D; Hesselbrock VM; Johnson EO; Kramer JR; Kuperman S; Meyers JL; Nurnberger J; Porjesz B; Saccone NL; Schuckit MA; Stitzel J; Tischfield JA; Rice JP; Goate A; Bierut LJ
Addict Biol; 2018 Jan; 23(1):437-447. PubMed ID: 28032407
[TBL] [Abstract][Full Text] [Related]
19. Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
Rao Y; Hoffmann E; Zia M; Bodin L; Zeman M; Sellers EM; Tyndale RF
Mol Pharmacol; 2000 Oct; 58(4):747-55. PubMed ID: 10999944
[TBL] [Abstract][Full Text] [Related]
20. A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.
Al Koudsi N; Ahluwalia JS; Lin SK; Sellers EM; Tyndale RF
Pharmacogenomics J; 2009 Aug; 9(4):274-82. PubMed ID: 19365400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
